Back to research
Data as of 9 min read

Word-of-Mouth in UK Pre-Med Circles Hands Medify 2 in 3 UCAT Applicants, Harvesting Seasonal Millions Every July–September

Founded in 2009 by then-pre-med student Dr. Sajeev Shanmuganandarajah, UK-based Medify has grown into a self-funded, 17-person medical and dental admissions platform (winning a 2021 BETT Award) covering UCAT, UCAT ANZ, GAMSAT, interviews, and A Levels. Priced around intense sprint windows (£15/wk, £30/mo, £210/yr; $35/$65/$450 USD), it reports 250,000+ lifetime students and usage by 2 in 3 UK applicants. Web traffic spikes cleanly onto the UCAT exam window (55,829 in July; 44,429 in August), while 'Medify average scores' serve as the unofficial benchmark across student forums.

Who it is for
UK, Australian, and New Zealand medical and dental school applicants plus secondary-school career advisors—a hyper-anxious, high-willingness-to-pay exam cohort.
How it charges
Exam-sprint subscription tiers: £15/week, £30/month, or £210/year in the UK ($35/week, $65/month, $450/year USD), engineered to extract peak value from 4-to-12-week pre-exam sprints.
01

Executive Summary

What this business is

Customers

UK, Australian, and New Zealand medical and dental school applicants plus secondary-school career advisors—a hyper-anxious, high-willingness-to-pay exam cohort.

Offering

An online medical and dental admissions prep suite anchored by an interactive UCAT (formerly UKCAT) question bank, timed mock exams, and video/written explanations—expanded across UCAT ANZ, GAMSAT, admissions interviews, A Levels, and school guidance portals.

Business model

Bootstrapped cohort-relay EdTech: establish authentic timed mocks, dominate student forums so passing seniors hand Medify down to incoming juniors every summer, capture UCAT search intent, and harvest annual exam-window revenue without VC burn.

Pricing

Exam-sprint subscription tiers: £15/week, £30/month, or £210/year in the UK ($35/week, $65/month, $450/year USD), engineered to extract peak value from 4-to-12-week pre-exam sprints.

Takeoff mode
Student-Forum Relay Compounding (2010 Launch → 2015 TSR Default → 2 in 3 UK Applicant Share)
Positioning
Medical & dental school admissions prep (UCAT, UCAT ANZ, GAMSAT, Interviews, A Levels)
Core Pricing
Sprint subscriptions: £15/week · £30/month · £210/year ($35 / $65 / $450 USD)
Founder & Team
Dr. Sajeev Shanmuganandarajah (physician & CEO); 17 listed staff, bootstrapped (BETT 2021 winner)

Unlike traditional paper A Levels, the UCAT/UKCAT is a fiercely time-pressured computer-based test. In 2009–2015, prep meant flipping through clunky paper workbooks (like the famous 600-question book) that completely failed to mimic on-screen timing stress. As a pre-med applicant himself, Sajeev rebuilt the exact digital exam interface online—leading top-scoring seniors on The Student Room as early as 2015 to tell juniors: 'Buy Medify, throw away the 600-question book.'

Test-prep businesses die when they force casual 6-week crammers into rigid £200+ annual contracts. By pricing weekly (£15/wk) and monthly (£30/mo) sprints alongside a £210 annual option—and segmenting international dollar buyers higher ($35/wk, $65/mo, $450/yr)—Medify captures almost every wallet in the funnel. With 30,000+ UK UCAT sitters annually, hitting 2/3 penetration at an average £30–£60 spend explains how a bootstrapped 17-person UK company sustains million-pound annual economics every July–August peak.

Founder and CEO Dr. Sajeev Shanmuganandarajah started Medify in 2009 while preparing for the UKCAT himself as a pre-med applicant (registering medify.co.uk in October 2009, later shifting to medify.co in 2014) and went on to qualify as a practicing physician. Rather than raising VC, he reinvested profits into a 17-person staff blending doctors, medical students, educators, and software engineers—winning a 2021 BETT Award along the way.

Preparing your reading

A work in progress.

2026.11.08 · V0.4

Refined product categories and extension rankings. Added one-line Agent setup and three membership options.